Clin2
NCT06431932Worth exploringRecruiting

Fisetin for healthy and older adults with multiple conditions

MultimorbidityHealthy

Treatments studied

This trial tests a pill called fisetin, which may help clear aging cells from the body. It is studying two groups: healthy younger adults and older adults with multiple health problems who have recently been in the hospital.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You are either 20–35 years old and generally healthy, or 65+ and recently hospitalized with two or more chronic conditions
  • You must be able to read and understand Danish
  • You cannot weigh more than 100 kg (220 lbs)
  • You must be able to swallow pills
  • You cannot be taking anti-aging supplements like fisetin or quercetin
  • You cannot have a history of cancer (except non-melanoma skin cancer) or be on cancer treatment

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07195318Recruiting
Fisetin supplement study for healthy aging

This study tests whether a natural supplement called fisetin can help people age more healthily. It is for Danish-speaking adults aged 50 and older who are not taking certain other supplements or medications.

Hvidovre
NCT06796374Recruiting
Comparing fisetin in young and older adults

This trial compares how the body processes fisetin, a natural substance found in fruits and vegetables, in young adults (18–30) and older adults (65+). It aims to see if age affects how fisetin works, which could help in future treatments for aging-related conditions.

Greifswald
NCT03675724Enrolling by invitation· Phase 2
Fisetin for frailty and inflammation in older adults

This trial studies whether fisetin, a supplement-like drug, can reduce frailty and inflammation in people age 70 and older. It may help improve health measures related to aging, but you must meet several safety and medication rules to join.

Rochester, Minnesota
NCT03430037Enrolling by invitation· Phase 2
Fisetin study to reduce frailty and inflammation in older women

This Phase 2 trial tests whether fisetin, a supplement, can reduce frailty and inflammation in postmenopausal women age 70 and older. If it works, it may help older adults feel stronger and have healthier body signals related to aging and inflammation.

Rochester, Minnesota
NCT07676435Recruiting· Phase 2
Fisetin trial for healthy lung aging

This study tests whether a natural supplement called fisetin can help slow lung decline in older adults who are either lifelong nonsmokers or long-term smokers. You would take fisetin or a placebo for a period and be monitored regularly.

Los Angeles, California
NCT06819254Recruiting· Phase 4
Fisetin for fatigue in older cancer survivors

This study tests whether a natural compound called fisetin can reduce fatigue in people aged 60+ who have completed cancer treatment. If you still feel tired often, this pill-based treatment might help you regain energy.

Winston-Salem, North Carolina

Hear when a new Multimorbidity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.